Compare CareRx Corp. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 233 Million (Small Cap)
8.00
NA
0.00%
0.27
25.11%
2.13
Revenue and Profits:
Net Sales:
96 Million
(Quarterly Results - Dec 2025)
Net Profit:
24 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.63%
0%
-2.63%
6 Months
5.71%
0%
5.71%
1 Year
42.31%
0%
42.31%
2 Years
92.71%
0%
92.71%
3 Years
66.67%
0%
66.67%
4 Years
-27.17%
0%
-27.17%
5 Years
-27.88%
0%
-27.88%
CareRx Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.95%
EBIT Growth (5y)
64.10%
EBIT to Interest (avg)
0.46
Debt to EBITDA (avg)
2.68
Net Debt to Equity (avg)
0.41
Sales to Capital Employed (avg)
2.57
Tax Ratio
0.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
4.21%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
2.13
EV to EBIT
22.08
EV to EBITDA
8.68
EV to Capital Employed
1.89
EV to Sales
0.71
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
8.55%
ROE (Latest)
25.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Dec 2016
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.06%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
96.10
93.20
3.11%
Operating Profit (PBDIT) excl Other Income
7.50
7.80
-3.85%
Interest
1.60
1.70
-5.88%
Exceptional Items
-0.20
-0.10
-100.00%
Consolidate Net Profit
23.80
1.50
1,486.67%
Operating Profit Margin (Excl OI)
31.20%
36.00%
-0.48%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 3.11% vs 1.97% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 1,486.67% vs 150.00% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
370.20
366.70
0.95%
Operating Profit (PBDIT) excl Other Income
30.20
26.60
13.53%
Interest
6.80
9.20
-26.09%
Exceptional Items
-1.40
-2.10
33.33%
Consolidate Net Profit
26.10
-4.50
680.00%
Operating Profit Margin (Excl OI)
32.10%
20.30%
1.18%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.95% vs -1.08% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 680.00% vs 16.67% in Dec 2024
About CareRx Corp. 
CareRx Corp.
Pharmaceuticals & Biotechnology
CareRx Corporation (CareRx), formerly Centric Health Corporation, is a Canada-based provider of pharmacy services and solutions to home operators and residents. The Company offers a range of medication solutions. CareRx provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. The Company serves long-term care, retirement and assisted living, and supportive housing and group homes. CareRx offers a range of technology and program solutions, which includes eMAR Integration, Digital Prescribing, Nursing Portal and Karie Medication Dispenser.
Company Coordinates 
Company Details
20 Eglinton Ave W , TORONTO ON : M4R 1K8
Registrar Details






